|
Reaction Name | Pathway Name / Pathway No. | Kf | Kb | Kd | tau | Reagents |
1 | cAMP-bind-site-B 1 | PKA
Pathway No. 270 | 54 (uM^-1 s^-1) | 33 (s^-1) | Kd(bf) = 0.6111(uM) | - | Substrate: R2C2 cAMP
Products: R2C2-cAMP
|
| Hasler et al FASEB J 6:2734-2741 1992 say Kd =1e-7M for type II, 5.6e-8 M for type I. Take mean which comes to 2e-13 #/cell Smith et al PNAS USA 78:3 1591-1595 1981 have better data. First kf/kb=2.1e7/M = 3.5e-5 (#/cell). Ogreid and Doskeland Febs Lett 129:2 287-292 1981 have figs suggesting time course of complete assoc is < 1 min. | 2 | cAMP-bind-site-B 2 | PKA
Pathway No. 270 | 54 (uM^-1 s^-1) | 33 (s^-1) | Kd(bf) = 0.6111(uM) | - | Substrate: R2C2-cAMP cAMP
Products: R2C2-cAMP2
|
| For now let us set this to the same Km (1e-7M) as site B. This gives kf/kb = .7e-7M * 1e6 / (6e5^2) : 1/(6e5^2) = 2e-13:2.77e-12 Smith et al have better values. They say that this is cooperative, so the consts are now kf/kb =8.3e-4 | 3 | cAMP-bind-site-A 1 | PKA
Pathway No. 270 | 75.0006 (uM^-1 s^-1) | 110 (s^-1) | Kd(bf) = 1.4667(uM) | - | Substrate: R2C2-cAMP2 cAMP
Products: R2C2-cAMP3
|
4 | cAMP-bind-site-A 2 | PKA
Pathway No. 270 | 75.0006 (uM^-1 s^-1) | 32.5 (s^-1) | Kd(bf) = 0.4333(uM) | - | Substrate: cAMP R2C2-cAMP3
Products: R2C2-cAMP4
|
5 | Release-C1 | PKA
Pathway No. 270 | 60 (s^-1) | 17.9998 (uM^-1 s^-1) | Kd(cb) = 0.3(uM) | - | Substrate: R2C2-cAMP4
Products: PKA-active R2C-cAMP4
|
| This has to be fast, as the activation of PKA by cAMP is also fast. kf was 10 | 6 | Release-C2 | PKA
Pathway No. 270 | 60 (s^-1) | 17.9998 (uM^-1 s^-1) | Kd(cb) = 0.3(uM) | - | Substrate: R2C-cAMP4
Products: PKA-active R2-cAMP4
|
7 | inhib-PKA | PKA
Pathway No. 270 | 59.9994 (uM^-1 s^-1) | 1 (s^-1) | Kd(bf) = 0.0167(uM) | - | Substrate: PKA-active PKA-inhibitor
Products: inhibited-PKA
|
| This has to be set to zero for matching the expts in vitro. In vivo we need to consider the inhibition though. kf = 1e-5 kb = 1 | 8 | CaM_bind_PDE1 | AC
Pathway No. 269 | 719.982 (uM^-1 s^-1) | 5 (s^-1) | Kd(bf) = 0.0069(uM) | - | Substrate: PDE1 CaM-Ca4
Products: CaM.PDE1
|
| For olf epi PDE1, affinity is 7 nM. Assume same for brain. Reaction should be pretty fast. Assume kb = 5/sec. Then kf = 5 / (0.007 * 6e5) = 1.2e-3 | 9 | CaM-bind-AC1 | AC
Pathway No. 269 | 49.9997 (uM^-1 s^-1) | 1 (s^-1) | Kd(bf) = 0.02(uM) | - | Substrate: CaM-Ca4 AC1
Products: AC1-CaM
|
| Half-max at 20 nM CaM (Tang et al JBC 266:13 8595-8603 1991 kb/kf = 20 nM = 12000 #/cell so kf = kb/12000 = kb * 8.333e-5 | 10 | dephosph-AC2 | AC
Pathway No. 269 | 0.1 (s^-1) | 0 (s^-1) | - | - | Substrate: AC2*
Products: AC2
|
| Random rate. | 11 | dephosph-PDE | AC
Pathway No. 269 | 0.01 (s^-1) | 0 (s^-1) | - | - | Substrate: cAMP-PDE*
Products: cAMP-PDE
|
| The rates for this are poorly constrained. In adipocytes (probably a different PDE) the dephosphorylation is complete within 15 min, but there are no intermediate time points so it could be much faster. Identity of phosphatase etc is still unknown. | 12 | cAMP_diffusion | AC
Pathway No. 269 | 300 (s^-1) | 5.4 (s^-1) | Not applicable** | - | Substrate: cAMP
Products: cAMP_in_dend
|
| Represents diffusion, from a volume of 9e-20 to 5e-18. Assuming neck dimensions of 0.1 x 0.1 microns, this works out to a diffusion const of about 270 um^2/sec, which is pretty conservative. It is what cAMP does in frog cilia. | 13 | dissoc-PP1-I1 | PP1_PSD
Pathway No. 268 | 1 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate: PP1-I1
Products: I1 PP1-active_PSD
|
| Let us assume that the equil in this case is very far over to the right. This is probably safe. | 14 | Ca-bind-CaNAB-Ca 2 | PP2B
Pathway No. 267 | 3.6001 (uM^-2 s^-1) | 1 (s^-1) | Kd(af) = 0.527(uM) | - | Substrate: Ca Ca CaNAB-Ca2
Products: CaNAB-Ca4
|
| This process is probably much more complicated and involves CaM. However, as I can't find detailed info I am bundling this into a single step. Based on Steemer and Klee pg 6863, the Kact is 0.5 uM. kf/kb = 1/(0.5 * 6e5)^2 = 1.11e-11 | 15 | Ca-bind-CaNAB | PP2B
Pathway No. 267 | 10008 (uM^-2 s^-1) | 1 (s^-1) | Kd(af) = 0.01(uM) | - | Substrate: CaNAB Ca Ca
Products: CaNAB-Ca2
|
| going on the experience with CaM, we put the fast (high affinity) sites first. We only know (Stemmer and Klee) that the affinity is < 70 nM. Assuming 10 nM at first, we get kf = 2.78e-8, kb = 1. Try 20 nM. kf = 7e-9, kb = 1 | 16 | CaMCa4-bind-CaNA B | PP2B
Pathway No. 267 | 599.994 (uM^-1 s^-1) | 1 (s^-1) | Kd(bf) = 0.0017(uM) | - | Substrate: CaM-Ca4 CaNAB-Ca4
Products: CaM_Ca_n-CaNAB
|
17 | Inact-PP1 | PP1
Pathway No. 266 | 499.981 (uM^-1 s^-1) | 0.1 (s^-1) | Kd(bf) = 0.0002(uM) | - | Substrate: I1* PP1-active
Products: PP1-I1*
|
| K inhib = 1nM from Cohen Ann Rev Bioch 1989, 4 nM from Foukes et al Assume 2 nM. kf /kb = 8.333e-4 | 18 | dissoc-PP1-I1 | PP1
Pathway No. 266 | 1 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate: PP1-I1
Products: PP1-active I1
|
| Let us assume that the equil in this case is very far over to the right. This is probably safe. | 19 | CaM-TR2-bind-Ca | CaM
Pathway No. 265 | 71.999 (uM^-2 s^-1) | 72 (s^-1) | Kd(af) = 1(uM) | - | Substrate: CaM Ca Ca
Products: CaM-TR2-Ca2
|
| Lets use the fast rate consts here. Since the rates are so different, I am not sure whether the order is relevant. These correspond to the TR2C fragment. We use the Martin et al rates here, plus the Drabicowski binding consts. All are scaled by 3X to cell temp. kf = 2e-10 kb = 72 Stemmer & Klee: K1=.9, K2=1.1. Assume 1.0uM for both. kb/kf=3.6e11. If kb=72, kf = 2e-10 (Exactly the same !).... | 20 | CaM-TR2-Ca2-bind -Ca | CaM
Pathway No. 265 | 3.6 (uM^-1 s^-1) | 10 (s^-1) | Kd(bf) = 2.7778(uM) | - | Substrate: CaM-TR2-Ca2 Ca
Products: CaM-Ca3
|
| K3 = 21.5, K4 = 2.8. Assuming that the K4 step happens first, we get kb/kf = 2.8 uM = 1.68e6 so kf =6e-6 assuming kb = 10 |